
NASDAQHealthcareBiotechnology
Latest quote
$4.25
−$0.095 · -2.19%
NOMAD Power Solutions, Inc., through its wholly owned subsidiary NOMAD Transportable Power Systems, provides transportable, utility-grade battery energy storage systems. The company's mobile battery energy storage system (BESS) platforms deliver rapidly deployable, scalable energy solutions for electric utilities, data centers, commercial and industrial customers, emergency response, renewable energy integration, and grid modernization. The company also continues to advance a life sciences portfolio, including the development of novel oncology therapeutics.
Previous close
$4.25
−$0.095 · -2.19%
After-hours
$4.25
$0.00 · 0.00%
Oct 7, 7:30 PM ET
Regular session · ET · Market data may be delayed.
NOMAD Power Solutions, Inc., through its wholly owned subsidiary NOMAD Transportable Power Systems, provides transportable, utility-grade battery energy storage systems. The company's mobile battery energy storage system (BESS) platforms deliver rapidly deployable, scalable energy solutions for electric utilities, data centers, commercial and industrial customers, emergency response, renewable energy integration, and grid modernization. The company also continues to advance a life sciences portfolio, including the development of novel oncology therapeutics.
Day range
Current $4.25
52-week range
Current $4.25
Regular session · ET · Market data may be delayed.
NOMAD Power Solutions, Inc., through its wholly owned subsidiary NOMAD Transportable Power Systems, provides transportable, utility-grade battery energy storage systems. The company's mobile battery energy storage system (BESS) platforms deliver rapidly deployable, scalable energy solutions for electric utilities, data centers, commercial and industrial customers, emergency response, renewable energy integration, and grid modernization. The company also continues to advance a life sciences portfolio, including the development of novel oncology therapeutics.
Day range
Current $4.25
52-week range
Current $4.25
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development | 254.92K USD | 726.23K USD | 898.1K USD | 1.35M USD | 1.74M USD |
| Selling, general, and administrative | 4.85M USD | 2.85M USD | 4.19M USD | 4.96M USD | 4.98M USD |
| Operating expenses | 5.11M USD | 3.57M USD | 5.09M USD | 6.31M USD | 6.72M USD |
| Interest income | 7.39K USD | 7.05K USD | 17.49K USD | 11.2K USD | 626 USD |
| Interest expense | 9.16K USD | 16.82K USD | 16.23K USD | 8.88K USD | — |
| Operating income | −5.11M USD | −3.57M USD | −5.09M USD | −6.31M USD | −6.72M USD |
| Net income | −6.01M USD | −3.59M USD | −5.09M USD | −6.31M USD | −6.73M USD |
Company facts updated Oct 8, 2026.
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
iShares Micro-Cap ETFIWCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.